8月11日，超研股份今日收盘28.68元，上涨5.13%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到77.61倍，创114天以来新低，总市值122.84亿元。 来源：金融界 序号股票简称PE(TTM)PE(静)市净率总市值(元)13超研股份77.6184.389.50122.84亿行业平均 56.5652.664.92118.97亿行业中值39.7639.192.9457.67亿1九安医疗11.2811.400.89190.28亿2英科医疗 15.1416.331.35239.25亿3山东药玻16.1616.211.86152.83亿4振德医疗16.7615.801.0760.86亿5新华医疗 17.1715.911.40110.05亿6奥美医疗17.1816.831.7762.06亿7九强生物17.8916.632.1988.59亿8康德莱 18.3218.341.5239.49亿9维力医疗18.6219.892.3443.64亿10奥泰生物18.7119.731.5159.67亿11鱼跃医疗 20.1519.762.72356.78亿12三鑫医疗20.8121.623.6549.16亿 ...

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Chao Yan Co., Ltd. in the medical device industry, noting its current stock price and market capitalization [1][2] - As of July 30, Chao Yan Co., Ltd. closed at 27.22 yuan, with a rolling PE ratio of 73.66, marking a new low in 17 days, and a total market value of 11.659 billion yuan [1] - The average PE ratio for the medical device industry is 55.15, with a median of 37.48, placing Chao Yan Co., Ltd. at the 94th position in the industry ranking [1][2] Group 2 - As of March 31, 2025, Chao Yan Co., Ltd. had 26,755 shareholders, a decrease of 23,411 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] - The main business of Chao Yan Co., Ltd. includes the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products being industrial ultrasound, medical ultrasound, X-ray, and accessories [1] - The company has established a strong market presence and customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] - In 2022, Chao Yan Co., Ltd. received a second-class award for national defense technology invention from the Ministry of Industry and Information Technology for its project on new technology for high-precision non-destructive testing of complex large components [1] - For the first quarter of 2025, the company reported revenue of 98.43 million yuan, a year-on-year increase of 28.69%, and a net profit of 39.32 million yuan, up 47.70%, with a gross profit margin of 73.83% [1]

Company Overview - Chao Yan Co., Ltd. closed at 27.17 yuan, up 1.95%, with a rolling PE ratio of 73.53, marking a new low in 14 days, and a total market value of 11.638 billion yuan [1] - The company operates in the medical device industry, which has an average PE ratio of 55.41 and a median of 37.94, placing Chao Yan at the 96th position in the industry ranking [1] - As of the first quarter of 2025, 118 institutions held shares in Chao Yan, with a total holding of 71,100 shares valued at 0.02 billion yuan [1] Business Operations - Chao Yan specializes in the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment [1] - The main products include industrial ultrasound, medical ultrasound, X-ray, and related accessories [1] - The company has established a strong market presence and stable customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand [1] - In 2022, the company received a second-class National Defense Technology Invention Award from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" [1] Financial Performance - In the first quarter of 2025, Chao Yan reported operating revenue of 98.4324 million yuan, a year-on-year increase of 28.69% [1] - The net profit for the same period was 39.3220 million yuan, reflecting a year-on-year growth of 47.70% [1] - The sales gross margin stood at 73.83% [1]

Core Viewpoint - Chao Yan Co., Ltd. has seen its stock price rise to 26.63 yuan, with a rolling PE ratio of 72.07, marking a new low in 63 days, and a total market capitalization of 11.406 billion yuan [1] Company Summary - Chao Yan Co., Ltd. specializes in the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products including industrial ultrasound, medical ultrasound, X-ray, and accessories [1] - The company has established a strong market presence and stable customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] - In 2022, the company received a second-class National Defense Technology Invention Award from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" [1] - For Q1 2025, the company reported revenue of 98.4324 million yuan, a year-on-year increase of 28.69%, and a net profit of 39.322 million yuan, up 47.70%, with a gross profit margin of 73.83% [1] Industry Summary - The average PE ratio for the medical device industry is 51.42, with a median of 37.44, positioning Chao Yan Co., Ltd. at 96th place in the industry ranking [1] - The static PE ratio for Chao Yan Co., Ltd. is 78.35, and the price-to-book ratio is 8.82 [2] - The total market capitalization of the medical device industry is 106.60 billion yuan [2]

Core Viewpoint - Chao Yan Co., Ltd. has a closing price of 24.78 yuan, down 1.82%, with a rolling PE ratio of 67.06 times and a total market value of 10.614 billion yuan, indicating a higher valuation compared to the industry average [1] Company Summary - Chao Yan Co., Ltd. specializes in the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products including industrial ultrasound, medical ultrasound, X-ray, and accessories [1] - The company has established a strong market presence and customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] - In 2022, the company received the second prize of the National Defense Technology Invention Award from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" [1] Financial Performance - For the first quarter of 2025, the company reported operating revenue of 98.4324 million yuan, a year-on-year increase of 28.69%, and a net profit of 39.322 million yuan, a year-on-year increase of 47.70%, with a gross profit margin of 73.83% [1] Industry Summary - The average PE ratio for the medical device industry is 51.29 times, with a median of 37.02 times, positioning Chao Yan Co., Ltd. at the 96th rank within the industry [1][2] - The industry average market value is 10.675 billion yuan, while the median market value is 5.063 billion yuan [2]

Group 1 - The core viewpoint of the news is that Chao Yan Co., Ltd. has a high rolling price-to-earnings (PE) ratio of 70.66, significantly above the industry average of 50.64, indicating a premium valuation in the medical device sector [1][2] - As of June 9, the company's stock closed at 26.11 yuan, with a market capitalization of 11.184 billion yuan, reflecting a 1.28% increase [1] - The company has experienced a net outflow of main funds amounting to 245.27 million yuan on June 9, with a total outflow of 2,328.49 million yuan over the past five days [1] Group 2 - Chao Yan Co., Ltd. specializes in the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products including industrial ultrasound, medical ultrasound, and X-ray equipment [1] - The company has established a strong market presence and customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] - In 2022, the company received a second-class award for national defense technology invention from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" [1] Group 3 - The latest financial results for the first quarter of 2025 show that the company achieved an operating income of 98.4324 million yuan, representing a year-on-year increase of 28.69%, and a net profit of 39.3220 million yuan, up 47.70% year-on-year, with a gross profit margin of 73.83% [1]